Acquisition by Avi Mazaltov of 52500 shares of VBI Vaccines subject to Rule 16b-3

Slightly above 67% of VBI Vaccines' investor base is looking to short. The analysis of current outlook of investing in VBI Vaccines suggests that many traders are alarmed regarding VBI Vaccines' prospects. VBI Vaccines' investing sentiment can be driven by a variety of factors including economic data, VBI Vaccines' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Vbi Vaccines Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
VBI insider trading alert for grant of option right to buy common shares by Avi Mazaltov, Head Global MFGGM-SciVac Ltd., on 28th of July 2023. This event was filed by Vbi Vaccines Inc with SEC on 2023-07-28. Statement of changes in beneficial ownership - SEC Form 4

VBI Vaccines Fundamental Analysis

We analyze VBI Vaccines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

VBI Vaccines is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

VBI Vaccines Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VBI Vaccines stock to make a market-neutral strategy. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with similar companies.

Peers

VBI Vaccines Related Equities

JAGXJaguar Animal   29.29   
0%
100.0%
TNXPTonix Pharmaceuticals   15.00   
0%
51.0%
ANIXAnixa Biosciences   0.34   
1.0%
0%
ARDXArdelyx   1.50   
5.0%
0%
VXRTVaxart   1.64   
5.0%
0%
GOVXGeoVax Labs   1.64   
5.0%
0%
OCGNOcugen   2.30   
7.0%
0%
IBIOIbio   3.46   
11.0%
0%
AUPHAurinia Pharmaceuticals   4.15   
14.0%
0%
AKROAkero Therapeutics   4.35   
14.0%
0%
BBIOBridgeBio Pharma   4.52   
15.0%
0%
ALLOAllogene Therapeutics   5.61   
19.0%
0%
ANVSAnnovis Bio   6.71   
22.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in VBI Stock

If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets